Zebra Capital Management LLC Repligen Corp Transaction History

Zebra Capital Management LLC

  • $20 Million
  • Q1 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$122.51 - $158.27 $214,024 - $276,497
-1,747 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $164,794 - $245,418
1,747 New
1,747 $216,000

Others Institutions Holding RGEN

# of Institutions
485
Shares Held
54.1M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.21B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email